SECTOR:

Diagnostics/tools

FUND/VEHICLE:

NFLS Direct Investment

INVESTMENT DATE:

2017

GEOGRAPHY:

North America

STATUS CURRENT/FORMER INVESTMENT:

Existing

WEBSITE:

Grail is a diagnostics company formed by Illumina. The company is developing and commercializing a blood test for asymptomatic cancer screening via detection of circulating tumor DNA.